` Comparison: NYKD, VRTX - Alpha Spread

N
NYKD
vs
VRTX

Over the past 12 months, NYKD has significantly outperformed VRTX, delivering a return of +17% compared to the VRTX's 3% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NYKD
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

N
NYKD Intrinsic Value
0.492 NOK
Overvaluation 80%
Intrinsic Value
Price
VRTX Intrinsic Value
336.17 USD
Overvaluation 26%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
N
Nykode Therapeutics ASA
OSE:NYKD
2.466 NOK
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
452.04 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NYKD, VRTX

NYKD
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
N
Nykode Therapeutics ASA
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NYKD, VRTX

NYKD
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
N
Nykode Therapeutics ASA
OSE:NYKD
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NYKD
0%
VRTX
86.3%

Operating Margin

NYKD
-391.2%
VRTX
38.7%

Net Margin

NYKD
-162.4%
VRTX
31.4%

FCF Margin

NYKD
-518.2%
VRTX
28.5%

ROE

NYKD
-9.1%
VRTX
22.3%

ROA

NYKD
-8%
VRTX
15.6%

ROIC

NYKD
-24.2%
VRTX
25.1%

ROCE

NYKD
-20.9%
VRTX
23.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NYKD, VRTX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NYKD, VRTX

Loading
NYKD
VRTX
Difference
www.alphaspread.com

Performance By Year
NYKD, VRTX

Loading
NYKD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NYKD to other stocks
Unlock Full Access to Alpha Spread
Create Free Account